Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1442-9071.2009.02185.xDOI Listing

Publication Analysis

Top Keywords

pseudohypopyon intravitreal
4
intravitreal triamcinolone
4
triamcinolone acetonide
4
acetonide injection
4
injection phakic
4
phakic eye
4
pseudohypopyon
1
triamcinolone
1
acetonide
1
injection
1

Similar Publications

Background: Pseudophakic cystoid macular edema (CME) following primary anterior-chamber intraocular lens (ACIOL) implantations is commonly seen. Intravitreal triamcinolone acetonide (IVTA) injections have shown significant improvement in visual acuity and retinal thickness in refractory pseudophakic CME. Pseudohypopyon following IVTA injection is a known entity.

View Article and Find Full Text PDF

This case report aimed to describe the unusual clinical presentation and histopathological features of post-injection endophthalmitis. A 56-year-old male phakic patient with diabetic retinopathy received an intravitreal injection (Bevacizumab as per the patient) for neovascular glaucoma elsewhere and presented to our center one day after the dose with hypopyon. The eye was relatively white without pain or lid oedema.

View Article and Find Full Text PDF

To describe a patient who presented with visual loss and an apparent hypopyon but none of the other symptoms or signs most common with infectious endophthalmitis. A case and its findings were analyzed. A 73-year-old woman was treated with intravitreal triamcinolone acetonide (IVTA) for cystoid macular edema.

View Article and Find Full Text PDF

In this case report, we aim to describe a rare case of recurrent diffuse large B-cell lymphoma (DLBCL) reportedly in remission presenting with primary anterior segment findings and use of intravitreal bevacizumab and methotrexate to treat the sequelae. The patient presented with hypopyon and neovascularization of the iris (NVI). Anterior chamber studies including flow cytometry and imaging revealed DLBCL recurrence with central nervous system (CNS) involvement.

View Article and Find Full Text PDF

Purpose: To describe endogenous endophthalmitis in the setting of Covid-19 pneumonia post recovery.

Methods: Retrospective review of five patients of endogenous endophthalmitis following Covid-19 disease done.

Results: All five cases had received systemic corticosteroid for a mean duration of 7 days during severe Covid-19 treatment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!